Sio Capital Management
Latest statistics and disclosures from Sio Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CRIS, CVM, GLD, Spruce Biosciences, CHRS, and represent 23.02% of Sio Capital Management's stock portfolio.
- Added to shares of these 10 stocks: Spruce Biosciences (+$16M), AZN (+$13M), UHS (+$11M), CVM (+$11M), SNY (+$11M), AMGN (+$9.2M), MIRM (+$8.6M), VRTX (+$6.2M), ASGN (+$5.3M), IONS.
- Started 25 new stock positions in FUSN, SNY, OTRK, Vincera Pharma, SRRA, MIRM, VAPO, IOVA, MED, TRIL.
- Reduced shares in these 10 stocks: JNJ (-$17M), MCK (-$12M), MOH (-$10M), MESO (-$9.7M), AMN (-$9.7M), MCRB (-$9.0M), CAH (-$9.0M), , BMRN (-$8.2M), .
- Sold out of its positions in ATNM, ANTM, BNGO, CSII, CRBP, DYAI, ESPR, GSK, GDRX, JNJ.
- Sio Capital Management was a net seller of stock by $-89M.
- Sio Capital Management has $489M in assets under management (AUM), dropping by -3.26%.
Tip: Access up to 7 years of quarterly data
Positions held by Sio Capital Management, LLC consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sio Capital Management
Companies in the Sio Capital Management portfolio as of the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Curis Com New (CRIS) | 8.0 | $39M | -3% | 4.8M | 8.19 | |
| Cel-sci Corp Com Par New Put Option (CVM) | 5.1 | $25M | +77% | 2.1M | 11.66 | |
| Spdr Gold Shares Gold Shs (GLD) | 3.7 | $18M | -20% | 103k | 178.36 | |
| Spruce Biosciences | 3.2 | $16M | NEW | 637k | 24.31 | |
| Coherus Biosciences (CHRS) | 3.1 | $15M | -17% | 864k | 17.38 | |
| Albireo Pharma (ALBO) | 2.7 | $13M | -25% | 354k | 37.51 | |
| Hca Holdings (HCA) | 2.7 | $13M | -23% | 81k | 164.46 | |
| Astrazeneca Sponsored Adr (AZN) | 2.7 | $13M | NEW | 263k | 49.99 | |
| Cigna Corp (CI) | 2.7 | $13M | -23% | 62k | 208.17 | |
| AmerisourceBergen (ABC) | 2.6 | $13M | -22% | 128k | 97.76 | |
| Walgreen Boots Alliance (WBA) | 2.5 | $12M | +2% | 309k | 39.88 | |
| Hill-Rom Holdings (HRC) | 2.5 | $12M | -38% | 123k | 97.97 | |
| Universal Health Services CL B (UHS) | 2.3 | $11M | NEW | 81k | 137.50 | |
| Sanofi Sa Sponsored Adr (SNY) | 2.2 | $11M | NEW | 220k | 48.59 | |
Setup an alertSio Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Amgen (AMGN) | 1.9 | $9.2M | NEW | 40k | 229.93 | |
| AMN Healthcare Services (AMN) | 1.8 | $8.9M | -52% | 131k | 68.25 | |
| BioMarin Pharmaceutical (BMRN) | 1.8 | $8.8M | -48% | 101k | 87.69 | |
| Mirum Pharmaceuticals (MIRM) | 1.8 | $8.6M | NEW | 495k | 17.46 | |
| Cardinal Health (CAH) | 1.7 | $8.3M | -51% | 155k | 53.56 | |
| McKesson Corporation (MCK) | 1.7 | $8.3M | -59% | 48k | 173.93 | |
| Horizon Therapeutics SHS (HZNP) | 1.5 | $7.2M | -32% | 99k | 73.15 | |
| Becton, Dickinson and (BDX) | 1.4 | $6.8M | +64% | 27k | 250.24 | |
| Teva Pharmaceutical Industries Sponsored Ads (TEVA) | 1.4 | $6.7M | -27% | 690k | 9.65 | |
| Soliton (SOLY) | 1.4 | $6.6M | -15% | 862k | 7.68 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $6.2M | NEW | 26k | 236.34 | |
| Orthofix Medical (OFIX) | 1.2 | $6.0M | -36% | 139k | 42.98 | |
| United Therapeutics Corporation (UTHR) | 1.2 | $5.9M | -34% | 39k | 151.78 | |
| On Assignment (ASGN) | 1.1 | $5.3M | NEW | 63k | 83.53 | |
| Radius Health Com New (RDUS) | 1.1 | $5.2M | -57% | 293k | 17.86 | |
| Essa Pharma Com New (EPIX) | 1.1 | $5.2M | -33% | 433k | 11.93 | |
| Mersana Therapeutics (MRSN) | 1.0 | $4.9M | -36% | 185k | 26.61 | |
| Cellectar Biosciences Com Par (CLRB) | 1.0 | $4.8M | +70% | 2.3M | 2.08 | |
| Ionis Pharmaceuticals (IONS) | 0.9 | $4.6M | NEW | 81k | 56.54 | |
| Ardelyx (ARDX) | 0.9 | $4.5M | -8% | 689k | 6.47 | |
| Varex Imaging (VREX) | 0.9 | $4.4M | +131% | 267k | 16.68 | |
| Arena Pharmaceuticals Com New (ARNA) | 0.9 | $4.4M | -19% | 58k | 76.83 | |
| Syneos Health Cl A (SYNH) | 0.9 | $4.4M | -41% | 65k | 68.12 | |
| Kura Oncology (KURA) | 0.9 | $4.3M | +322% | 132k | 32.66 | |
| Cross Country Healthcare (CCRN) | 0.9 | $4.3M | +20% | 485k | 8.87 | |
| Chardan Healthcare Acquisition 2 Corp Unit (CHAQ.U) | 0.9 | $4.2M | 400k | 10.59 | ||
| Larimar Therapeutics (LRMR) | 0.8 | $4.0M | -37% | 189k | 21.41 | |
| Molina Healthcare (MOH) | 0.8 | $4.0M | -71% | 19k | 212.71 | |
| Gw Pharmaceuticals Ads (GWPH) | 0.8 | $3.9M | +64% | 34k | 115.41 | |
| Integer Hldgs (ITGR) | 0.8 | $3.8M | -63% | 47k | 81.18 | |
| Syndax Pharmaceuticals (SNDX) | 0.8 | $3.8M | +3447% | 170k | 22.24 | |
| Natus Medical (NTUS) | 0.8 | $3.7M | +79% | 187k | 20.04 | |
| Herbalife Nutrition Com Shs (HLF) | 0.8 | $3.7M | -12% | 78k | 48.06 | |
| Medifast Put Option (MED) | 0.7 | $3.6M | NEW | 18k | 196.32 | |
| Mesoblast Spons Adr Put Option (MESO) | 0.7 | $3.5M | -73% | 417k | 8.49 | |
| Viking Therapeutics (VKTX) | 0.7 | $3.4M | -14% | 610k | 5.63 | |
| Cymabay Therapeutics (CBAY) | 0.7 | $3.4M | -49% | 587k | 5.74 | |
| Health Sciences Acquisitions Corporation 2 Ord Shs (HSAQ) | 0.7 | $3.2M | 250k | 12.81 | ||
| Eucrates Biomedical Acquisition Corp. Unit 10/23/2027 | 0.7 | $3.2M | NEW | 300k | 10.66 | |
| Vincera Pharma | 0.6 | $3.1M | NEW | 150k | 20.91 | |
| Viewray (VRAY) | 0.6 | $3.0M | -61% | 775k | 3.82 | |
| Anika Therapeutics (ANIK) | 0.6 | $3.0M | -30% | 65k | 45.26 | |
| Cardiff Oncology (CRDF) | 0.6 | $2.7M | NEW | 150k | 17.99 | |
| Constellation Pharmceticls I (CNST) | 0.5 | $2.7M | NEW | 93k | 28.80 | |
| Precision Biosciences Ord (DTIL) | 0.5 | $2.6M | -10% | 318k | 8.34 | |
| Aslan Pharmaceuticals Ads (ASLN) | 0.5 | $2.5M | 1.4M | 1.83 | ||
| Iovance Biotherapeutics (IOVA) | 0.5 | $2.5M | NEW | 54k | 46.41 | |
| Sio Gene Therapies | 0.5 | $2.5M | NEW | 887k | 2.78 | |
| Cerecor (CERC) | 0.5 | $2.4M | -9% | 928k | 2.64 | |
| Ontrak (OTRK) | 0.5 | $2.4M | NEW | 38k | 61.78 | |
| Vapotherm (VAPO) | 0.4 | $2.1M | NEW | 78k | 26.86 | |
| Atreca Cl A Com (BCEL) | 0.4 | $2.1M | +63% | 129k | 16.15 | |
| Neubase Therapeutics Ord (NBSE) | 0.4 | $2.1M | -3% | 294k | 6.99 | |
| Fusion Pharmaceuticals (FUSN) | 0.4 | $2.0M | NEW | 173k | 11.75 | |
| Ayala Pharmaceuticals Incorporated (AYLA) | 0.4 | $1.7M | -2% | 157k | 11.00 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $1.7M | NEW | 146k | 11.71 | |
| Oncternal Therapeutics (ONCT) | 0.3 | $1.6M | NEW | 323k | 4.90 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $1.5M | -37% | 35k | 43.34 | |
| Salarius Pharmaceuticals Com New (SLRX) | 0.3 | $1.5M | NEW | 1.7M | 0.91 | |
| Aeglea Biotherapeutics (AGLE) | 0.3 | $1.5M | -9% | 191k | 7.87 | |
| Odonate Therapeutics Ord (ODT) | 0.3 | $1.5M | -44% | 76k | 19.21 | |
| Harrow Health (HROW) | 0.3 | $1.4M | -12% | 210k | 6.86 | |
| Catalyst Biosciences Com New (CBIO) | 0.2 | $1.2M | -5% | 189k | 6.31 | |
| Mei Pharma Com New (MEIP) | 0.2 | $1.1M | -4% | 426k | 2.64 | |
| Sierra Oncology Com New (SRRA) | 0.2 | $1.1M | NEW | 67k | 16.03 | |
| Alpha Healthcare Acquisition Corp Unit 09/21/2027 (AHACU) | 0.2 | $1.1M | 100k | 10.57 | ||
| Deerfield Healthcare Technology Acquisitions Corp Unit 07/16/2025 (DFHTU) | 0.2 | $750k | 50k | 15.00 | ||
| I-mab Sponsored Ads (IMAB) | 0.1 | $707k | 15k | 47.13 | ||
| Vincerx Pharma *w Exp 12/24/2025 | 0.1 | $693k | NEW | 210k | 3.30 | |
| Ideaya Biosciences (IDYA) | 0.1 | $676k | -12% | 48k | 14.00 | |
| Casi Pharmaceuticalsinc Com Stk (CASI) | 0.1 | $600k | -9% | 203k | 2.95 | |
| Neoleukin Therapeutics (NLTX) | 0.1 | $540k | 38k | 14.09 | ||
| Rapt Therapeutics (RAPT) | 0.1 | $282k | 14k | 19.72 | ||
| Trillium Therapeutics Com New (TRIL) | 0.0 | $228k | NEW | 16k | 14.71 | |
| Zosano Pharma Corp Com New (ZSAN) | 0.0 | $225k | -5% | 428k | 0.53 | |
Past Filings by Sio Capital Management
SEC 13F filings are viewable for Sio Capital Management going back to 2010
- Sio Capital Management 2020 Q4 filed Feb. 16, 2021
- Sio Capital Management 2020 Q3 filed Nov. 16, 2020
- Sio Capital Management 2020 Q2 filed Aug. 14, 2020
- Sio Capital Management 2020 Q1 filed May 15, 2020
- Sio Capital Management 2019 Q4 filed Feb. 14, 2020
- Sio Capital Management 2019 Q3 filed Nov. 14, 2019
- Sio Capital Management 2019 Q2 filed Aug. 14, 2019
- Sio Capital Management 2019 Q1 filed May 15, 2019
- Sio Capital Management 2018 Q4 filed Feb. 14, 2019
- Sio Capital Management 2018 Q3 filed Nov. 14, 2018
- Sio Capital Management 2018 Q2 filed Aug. 14, 2018
- Sio Capital Management 2018 Q1 filed May 15, 2018
- Sio Capital Management 2017 Q4 filed Feb. 14, 2018
- Sio Capital Management 2017 Q3 filed Nov. 14, 2017
- Sio Capital Management 2017 Q2 filed Aug. 14, 2017
- Sio Capital Management 2017 Q1 filed May 15, 2017